I reckon it's not the relationship that's watertight, it's the contract. My facts may be blurry, but -
As I understand it, that contract for 25 years exclusivity takes effect from a certain milestone - maybe the day we get approval to market from the FDA. Also, we use the injectable PPS so they can freely continue to market other forms.
I could be way off the mark here, just my thoughts.
research reports and media, page-4103
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $96.19M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 28.5¢ | 27.5¢ | $50.60K | 182.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1818 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 27600 | 2 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |